Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Conscious symptoms of learning and memory dysfunction in acrylamide-occupied workers

From: Reduction of eEF2 kinase alleviates the learning and memory impairment caused by acrylamide

Parameter

Exposed group (n = 50)

Non-exposed group (n = 50)

P

Subjective symptoms (n%)

   

Hypomnesiab

39(78.00)

27(54.00)

0.01

Unresponsiveb

25(50.00)

5(10.00)

< 0.0001

Giddyb

31(62.00)

14(28.00)

< 0.001

Headacheb

27(54.00)

5(10.00)

< 0.0001

Dreaminessb

28(56.00)

7(14.00)

< 0.0001

Hearing lossb

32(64.00)

6(12.00)

< 0.0001

Decreased visionb

28(56.00)

8(16.00)

< 0.0001

Melancholyb

16(32.00)

7(14.00)

0.03

  1. b Parameter values of exposed group and non-exposed group were compared using χ2 test